| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,701 |
8,417 |
$1.37M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,866 |
7,852 |
$967K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,665 |
3,069 |
$918K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,414 |
1,825 |
$729K |
| 80053 |
Comprehensive metabolic panel |
16,447 |
12,747 |
$664K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,499 |
1,275 |
$538K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
760 |
684 |
$472K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
880 |
779 |
$422K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,474 |
11,409 |
$393K |
| 87070 |
|
8,605 |
7,819 |
$295K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,954 |
2,714 |
$273K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,336 |
1,161 |
$255K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,877 |
2,036 |
$253K |
| 36415 |
Collection of venous blood by venipuncture |
32,711 |
15,490 |
$242K |
| 71046 |
Radiologic examination, chest; 2 views |
2,839 |
2,468 |
$204K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,136 |
1,959 |
$196K |
| 71045 |
Radiologic examination, chest; single view |
3,341 |
2,776 |
$191K |
| 80061 |
Lipid panel |
4,428 |
3,947 |
$161K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,104 |
3,771 |
$161K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,685 |
3,678 |
$155K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,271 |
3,789 |
$148K |
| 80305 |
|
1,710 |
1,450 |
$147K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
550 |
112 |
$142K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,640 |
3,052 |
$134K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,148 |
525 |
$133K |
| 73630 |
|
1,146 |
911 |
$129K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,057 |
1,529 |
$121K |
| 84484 |
|
3,334 |
2,376 |
$113K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,214 |
3,791 |
$109K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,359 |
3,159 |
$107K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,973 |
5,164 |
$100K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,500 |
1,327 |
$73K |
| G0378 |
Hospital observation service, per hour |
392 |
215 |
$71K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,103 |
2,708 |
$69K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,270 |
1,487 |
$61K |
| 83690 |
|
2,156 |
1,821 |
$58K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,168 |
2,309 |
$56K |
| 81001 |
|
3,820 |
3,303 |
$54K |
| 72100 |
|
545 |
463 |
$52K |
| 73610 |
|
534 |
467 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,310 |
2,436 |
$46K |
| 87631 |
|
362 |
344 |
$45K |
| 83735 |
|
1,528 |
1,186 |
$38K |
| 87186 |
|
1,254 |
1,092 |
$35K |
| 81025 |
|
1,393 |
1,273 |
$32K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
83 |
66 |
$30K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,484 |
1,869 |
$30K |
| 85027 |
|
1,736 |
1,546 |
$29K |
| 73130 |
|
318 |
278 |
$28K |
| 73562 |
|
317 |
259 |
$27K |
| 87077 |
|
1,602 |
1,216 |
$27K |
| 82150 |
|
840 |
721 |
$25K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
433 |
406 |
$25K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
714 |
520 |
$24K |
| 83880 |
|
353 |
296 |
$23K |
| 73030 |
|
268 |
219 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
563 |
402 |
$22K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
880 |
709 |
$22K |
| 87807 |
|
553 |
513 |
$21K |
| 82553 |
|
808 |
686 |
$20K |
| 81003 |
|
2,323 |
2,007 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
213 |
183 |
$20K |
| 85379 |
|
592 |
514 |
$19K |
| 97161 |
|
269 |
218 |
$18K |
| 74018 |
|
210 |
194 |
$17K |
| 82607 |
|
583 |
539 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
523 |
456 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
154 |
131 |
$13K |
| 96376 |
|
975 |
523 |
$12K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,432 |
1,113 |
$12K |
| 83540 |
|
355 |
326 |
$11K |
| 86803 |
|
299 |
265 |
$10K |
| 87040 |
|
198 |
141 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,515 |
2,090 |
$8K |
| 83605 |
|
404 |
331 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
992 |
583 |
$8K |
| 85610 |
|
231 |
191 |
$7K |
| 84466 |
|
223 |
205 |
$6K |
| 82043 |
|
258 |
230 |
$6K |
| 83874 |
|
185 |
163 |
$6K |
| J3490 |
Unclassified drugs |
467 |
362 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
26 |
24 |
$5K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
54 |
49 |
$5K |
| 72050 |
|
50 |
37 |
$5K |
| 82746 |
|
174 |
157 |
$4K |
| 74022 |
|
38 |
33 |
$4K |
| 90837 |
Psychotherapy, 53 minutes with patient |
25 |
13 |
$3K |
| 73110 |
|
32 |
28 |
$3K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
88 |
74 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
246 |
129 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
349 |
146 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
28 |
25 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
50 |
39 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
115 |
55 |
$2K |
| 84703 |
|
79 |
69 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
580 |
464 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
233 |
164 |
$2K |
| 95886 |
|
38 |
26 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
45 |
38 |
$2K |
| 86705 |
|
190 |
165 |
$2K |
| 82728 |
|
42 |
41 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16 |
12 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
135 |
116 |
$1K |
| 84439 |
|
45 |
41 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
326 |
113 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
102 |
72 |
$974.75 |
| 82550 |
|
27 |
25 |
$966.89 |
| 96367 |
|
14 |
13 |
$928.36 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
29 |
15 |
$903.12 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
54 |
53 |
$903.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
375 |
280 |
$852.88 |
| 36592 |
|
203 |
159 |
$849.98 |
| 80074 |
|
28 |
13 |
$837.73 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
46 |
13 |
$746.44 |
| 90715 |
|
34 |
30 |
$636.84 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
159 |
111 |
$624.79 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
102 |
26 |
$563.04 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
135 |
112 |
$529.19 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
22 |
12 |
$491.90 |
| 84480 |
|
13 |
13 |
$375.51 |
| 80320 |
|
12 |
12 |
$346.36 |
| J1953 |
Injection, levetiracetam, 10 mg |
82 |
72 |
$273.87 |
| 85730 |
|
16 |
13 |
$193.71 |
| 01992 |
|
34 |
29 |
$190.40 |
| 0012A |
|
13 |
12 |
$167.73 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
44 |
37 |
$134.40 |
| 12001 |
|
15 |
14 |
$116.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
14 |
$86.00 |
| 90686 |
|
14 |
14 |
$71.28 |
| J1435 |
Injection, estrone, per 1 mg |
24 |
24 |
$52.92 |
| 91301 |
|
13 |
12 |
$0.00 |